NUS

NEUTRAL

$7.3 Live

Nu Skin Enterprises, Inc. · NYSE

$5.63 52W Range $14.62

NUS Nu Skin Enterprises, Inc. - Fundamental Analysis

NEUTRAL

Console Chart News

NUS Stock | Fundamental Analysis & Investment Insights

NYSE • Consumer Defensive • Household & Personal Products

Current Price Live

$7.3

52W High

$14.62

52W Low

$5.63

Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers Insiders SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated May 01, 2026

Market cap

$358.99M

P/E

2.3

ROE

22.0%

Profit margin

10.8%

Debt/Equity

0.38

Dividend yield

3.29%

AI Analysis

AI-powered fundamental assessment

Confidence

85%

NUS presents a classic 'value trap' profile, characterized by a weak Piotroski F-Score of 3/9 and a bearish technical trend of 0/100. While the company is trading at a massive discount to its Graham Number ($34.57) and Intrinsic Value ($22.26), this is offset by a severe revenue contraction of -16.90% YoY. The balance sheet remains healthy with low debt (D/E 0.38) and strong liquidity, but the operational decay suggests the market is pricing in a permanent decline in the business model.

Key Strengths

Extremely low valuation (P/E 2.30, P/B 0.44)

Strong gross margins (69.45%)

Healthy liquidity with a Current Ratio of 2.08

Low leverage (Debt/Equity 0.38)

Sustainable dividend payout ratio (7.55%)

Key Risks

Significant revenue decline (-16.90% YoY)

Weak operational health (Piotroski F-Score 3/9)

Severe long-term price erosion (-83.6% over 5 years)

Bearish technical momentum (0/100 trend score)

Potential structural decline in the multi-level marketing/personal products industry

AI Fair Value Estimate

Based on comprehensive analysis

$14.75

+102.1% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Moderate

Value

Future

Past

Health

Dividend

AI Verdict

Deep Value / High Risk

Key drivers: Extreme valuation discount, Negative revenue growth, Weak Piotroski score, Strong balance sheet

Confidence

90%

Value

95/100

Ref P/E 2.30, P/B 0.44, Graham Number $34.57

Positives

P/E of 2.30 is exceptionally low
Trading at 44% of book value
Significant gap to Graham Number

Watchpoints

Low multiples may reflect lack of growth prospects

Future

20/100

Ref Revenue Growth -16.90%

Positives

Positive YoY EPS growth (+70.6%) likely due to cost cutting

Watchpoints

Revenue shrinking by nearly 17% YoY and Q/Q
Negative technical trend

Past

30/100

Ref 5Y Change -83.6%

Positives

Consistent earnings beats in recent quarters

Watchpoints

Catastrophic 5-year price performance (-83.6%)
Consistent downward trajectory

Health

35/100

Ref Piotroski F-Score 3/9

Positives

Low Debt/Equity ratio
Strong Current Ratio

Watchpoints

Piotroski F-Score 3/9 indicates weak financial health/trends

Dividend

50/100

Ref Yield 3.29%, Payout 7.55%

Positives

Very low payout ratio (7.55%)
Consistent yield of 3.29%

Watchpoints

Low overall dividend strength score (35/100)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$7.3

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for NUS and closest competitors.

Updated 2026-04-30

Company	5Y	3Y	1Y	6M	1M	1W
NUS Nu Skin Enterprises, Inc. Primary	-83.6%	-79.7%	+18.2%	-30.4%	+0.3%	-2.1%
OTLY Oatly Group AB Peer	-97.1%	-75.1%	+15.9%	-25.8%	+20.5%	-13.1%
BGS B&G Foods, Inc. Peer	-79.7%	-56.7%	-21.4%	+6.6%	+1.4%	+0.5%
MAGN Magnera Corporation Peer	-94.5%	-82.7%	-33.1%	+14.8%	+10.2%	-4.5%
LWAY Lifeway Foods, Inc. Peer	+343.6%	+305.3%	+3.4%	-7.7%	+16.7%	+7.2%

NUS

Nu Skin Enterprises, Inc.

Primary

-83.6%

-79.7%

+18.2%

-30.4%

+0.3%

-2.1%

OTL

Oatly Group AB

Peer

-97.1%

-75.1%

+15.9%

-25.8%

+20.5%

-13.1%

BGS

B&G Foods, Inc.

Peer

-79.7%

-56.7%

-21.4%

+6.6%

+1.4%

+0.5%

MAG

Magnera Corporation

Peer

-94.5%

-82.7%

-33.1%

+14.8%

+10.2%

-4.5%

LWA

Lifeway Foods, Inc.

Peer

+343.6%

+305.3%

+3.4%

-7.7%

+16.7%

+7.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

2.3

5.57

0.78

0.44

0.24

0.28

2.92

$358.99M

Profitability

Profit margins and return metrics

Profit Margin 10.79%

Operating Margin 6.28%

Gross Margin 69.45%

ROE 22.0%

ROA 3.95%

Growth

Revenue and earnings growth rates

Revenue Growth -16.9%

Earnings Growth N/A

Q/Q Revenue Growth -16.89%

Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

0.38

Low debt

Current Ratio

2.08

Strong

Quick Ratio

1.07

Good

Cash/Share

$5.03

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue

$0.4B

Gross Margin

70.7%

Op. Margin

6.3%

Net Margin

3.9%

Total Assets

$1.4B

Liabilities

$0.6B

Equity

$0.8B

Debt/Equity

0.75x

Operating CF

$0.0B

CapEx

$-0.0B

Free Cash Flow

$0.0B

FCF Yield

35%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-07

$N/A

2026-02-12

$0.29

-3.3% surprise

2025-11-06

$0.34

+13.3% surprise

2025-08-07

$0.43

+79.2% surprise

Consumer Defensive Sector Comparison

Comparing NUS against 194 companies in the Consumer Defensive sector (11 bullish, 69 neutral, 114 bearish)

P/E Ratio

2.3

This Stock

35.2

Sector Avg

-93.5% (Discount)

Return on Equity (ROE)

22.0%

This Stock

-12.23%

Sector Avg

-279.9% (Below Avg)

Profit Margin

10.79%

This Stock

-7.24%

Sector Avg

-249.1% (Weaker)

Debt to Equity

0.38

This Stock

1.9

Sector Avg

-79.8% (Less Debt)

Revenue Growth

-16.9%

This Stock

98.3%

Sector Avg

-117.2% (Slower)

Current Ratio

2.08

This Stock

2.23

Sector Avg

-6.7% (Weaker)

Similar Companies

Peer comparison within the same industry

Company	AI Rating	Market Cap	P/E	ROE	Profit Margin	Price
NUS Nu Skin Enterprises, Inc.	NEUTRAL	$358.99M	2.3	22.0%	10.8%	$7.3
OTLY Oatly Group AB	BEARISH	$361.9M	-	-243.4%	-17.7%	$11.59	Compare
BGS B&G Foods, Inc.	BEARISH	$352.82M	-	-40.9%	-13.6%	$4.41	Compare
MAGN Magnera Corporation	BEARISH	$351.37M	-	-12.4%	-4.0%	$9.87	Compare
LWAY Lifeway Foods, Inc.	BEARISH	$371.58M	27.42	17.6%	6.5%	$24.4	Compare

NUS Nu Skin Enterprises, Inc.

NEUTRAL

Mkt Cap

$359M

P/E

2.3

ROE

22.0%

Price

$7.3

Compare with NUS

Compare with NUS

MAGN Magnera Corporation

Compare with NUS

LWAY Lifeway Foods, Inc.

Compare with NUS

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date	Insider	Position	Transaction	Shares	Value
2026-03-11	WOODBURY EDWINA D	Director	Stock Award	14	$102
2026-03-06	THOMAS JAMES D.	Chief Financial Officer	Stock Award	114,706	-
2026-03-06	CLARK CHAYCE DAVID	Chief Operating Officer	Stock Award	138,971	-
2026-03-06	HATCHETT STEVEN KEITH	Officer	Stock Award	77,941	-
2026-03-06	KEISEL JUSTIN S	Officer	Stock Award	47,059	-
2026-03-06	NAPIERSKI RYAN S	Chief Executive Officer	Stock Award	282,353	-
2026-02-10	THOMAS JAMES D.	Chief Financial Officer	Stock Award	57,283	-
2026-02-10	CLARK CHAYCE DAVID	General Counsel	Stock Award	91,133	-
2026-02-10	HATCHETT STEVEN KEITH	Officer	Stock Award	52,076	-
2026-02-10	KEISEL JUSTIN S	Officer	Stock Award	37,410	-
2026-02-10	NAPIERSKI RYAN S	Chief Executive Officer	Stock Award	249,958	-
2025-12-10	WOODBURY EDWINA D	Director	Stock Award	10	$104
2025-11-11	HATCHETT STEVEN KEITH	Officer	Purchase	5,500	$52,855

WOODBURY EDWINA D

Director

Stock Award

2026-03-11

14 shares · $102

THOMAS JAMES D.

Chief Financial Officer

Stock Award

2026-03-06

114,706 shares

CLARK CHAYCE DAVID

Chief Operating Officer

Stock Award

2026-03-06

138,971 shares

HATCHETT STEVEN KEITH

Officer

Stock Award

2026-03-06

77,941 shares

KEISEL JUSTIN S

Officer

Stock Award

2026-03-06

47,059 shares

NAPIERSKI RYAN S

Chief Executive Officer

Stock Award

2026-03-06

282,353 shares

THOMAS JAMES D.

Chief Financial Officer

Stock Award

2026-02-10

57,283 shares

CLARK CHAYCE DAVID

General Counsel

Stock Award

2026-02-10

91,133 shares

HATCHETT STEVEN KEITH

Officer

Stock Award

2026-02-10

52,076 shares

KEISEL JUSTIN S

Officer

Stock Award

2026-02-10

37,410 shares

NAPIERSKI RYAN S

Chief Executive Officer

Stock Award

2026-02-10

249,958 shares

WOODBURY EDWINA D

Director

Stock Award

2025-12-10

10 shares · $104

HATCHETT STEVEN KEITH

Officer

Buy

2025-11-11

5,500 shares · $52,855

Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A

2026 PROXY STATEMENT

2026-04-03

NUS filed its 2026 definitive proxy statement on April 3, 2026, providing shareholders with necessary information for the upcoming annual meeting.

8-K

FORM 8-K

2026-03-27

8-K

FORM 8-K

2026-03-20

8-K

FORM 8-K

2026-03-09

10-K

FORM 10-K

2026-02-13

NUS submitted its annual 10-K filing on February 13, 2026, which includes comprehensive disclosures on its business operations, distribution channels, and geographic regions. The filing contains dedicated sections for risk factors and management's discussion and analysis of financial condition, though specific financial metrics were not provided in the excerpts.

8-K

FORM 8-K

2026-02-12

NuScale Power Corporation likely filed this 8-K to announce its annual financial results for the preceding fiscal year.

10-Q

FORM 10-Q

2025-11-07

NUS submitted its Form 10-Q filing on November 7, 2025. While the filing includes a section for Risk Factors under Item 1A, no specific financial highlights or detailed risk disclosures were provided in the available excerpt.

8-K

FORM 8-K

2025-11-06

NuScale Power Corporation filed an 8-K on November 6, 2025, likely to announce its third-quarter financial results.

10-Q

FORM 10-Q

2025-08-08

NUS submitted its Form 10-Q filing on August 8, 2025. While the document includes a section for Risk Factors under Item 1A, no specific financial highlights or detailed risk disclosures were provided in the available excerpt.

8-K

FORM 8-K

2025-08-07

NuScale Power Corporation filed an 8-K on August 7, 2025, likely to announce its second-quarter financial results.

8-K

FORM 8-K

2025-05-30

10-Q

2025-05-09

8-K

FORM 8-K

2025-05-08

DEF 14A

2025 PROXY STATEMENT

2025-04-04

8-K

FORM 8-K

2025-03-06

Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning NUS from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V2 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends

NUS

NUS Nu Skin Enterprises, Inc. - Fundamental Analysis

At a glance

AI Analysis

Key Strengths

Key Risks

Performance Snowflake

Stock Price & Analyst Targets

Multi-Horizon Performance vs Peers

Historical Performance Trends

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Valuation Metrics

Profitability

Growth

Financial Health

Financial Statement Flow

Quarterly Earnings History

Consumer Defensive Sector Comparison

Similar Companies

Recent Insider Trading

SEC Filings

Past News Coverage

Wait — Don't Miss Out!